Select Medical Holdings Co. (NYSE:SEM) Declares $0.13 Quarterly Dividend

Select Medical Holdings Co. (NYSE:SEM) declared a quarterly dividend on Wednesday, October 30th,NASDAQ Dividends reports. Stockholders of record on Wednesday, November 13th will be given a dividend of 0.125 per share by the health services provider on Tuesday, November 26th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.24%. The ex-dividend date of this dividend is Wednesday, November 13th.

Select Medical has a dividend payout ratio of 22.4% meaning its dividend is sufficiently covered by earnings. Analysts expect Select Medical to earn $2.19 per share next year, which means the company should continue to be able to cover its $0.50 annual dividend with an expected future payout ratio of 22.8%.

Select Medical Price Performance

NYSE SEM opened at $40.20 on Tuesday. The company has a market cap of $5.20 billion, a PE ratio of 18.79, a P/E/G ratio of 2.04 and a beta of 1.42. The firm’s 50 day moving average price is $34.48 and its 200-day moving average price is $34.44. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. Select Medical has a 52-week low of $21.56 and a 52-week high of $40.98.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.07. The business had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The business’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.46 EPS. Sell-side analysts forecast that Select Medical will post 2.16 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have commented on SEM shares. StockNews.com lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Tuesday, November 5th. Royal Bank of Canada increased their target price on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Bank of America assumed coverage on Select Medical in a research report on Tuesday, August 20th. They set a “buy” rating and a $42.00 price target on the stock. Finally, Benchmark reissued a “buy” rating and issued a $48.00 price objective on shares of Select Medical in a research report on Friday, November 1st. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $40.75.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.